732278-52-3 Usage
Uses
Used in Pharmaceutical Industry:
BDZ-g,GYKI 47409, is used as a central nervous system depressant for its interaction with GABA receptors, which helps in the regulation of anxiety and sedation.
Used in Neurodegenerative Disease Treatment:
BDZ-g,GYKI 47409, is used as a selective AMPA receptor antagonist for modulating the activity of the neurotransmitter glutamate in the brain, which could be beneficial in the treatment of neurodegenerative diseases or chronic pain conditions where glutamate dysregulation is implicated.
Check Digit Verification of cas no
The CAS Registry Mumber 732278-52-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,3,2,2,7 and 8 respectively; the second part has 2 digits, 5 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 732278-52:
(8*7)+(7*3)+(6*2)+(5*2)+(4*7)+(3*8)+(2*5)+(1*2)=163
163 % 10 = 3
So 732278-52-3 is a valid CAS Registry Number.
732278-52-3Relevant academic research and scientific papers
Novel substituted 2,3-benzodiazepine derivatives
-
Page/Page column 26, (2010/02/08)
The invention relates to new 2,3-benzodiazepine derivatives of formula (I), isomers and acid addition salts thereof and to pharmaceutical compositions containing the same, as well as to pharmaceutical compositions and methods of using the same suitable fo
